105 related articles for article (PubMed ID: 2252961)
21. Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation.
Dietzfelbinger HF; Kühn D; Zafferani M; Hanauske AR; Rastetter JW; Berdel WE
Cancer Res; 1993 Aug; 53(16):3747-51. PubMed ID: 8339286
[TBL] [Abstract][Full Text] [Related]
22. Peripheral blood and bone marrow hematopoietic stem cells: are they the same?
Janssen WE
Semin Oncol; 1993 Oct; 20(5 Suppl 6):19-27. PubMed ID: 8211212
[TBL] [Abstract][Full Text] [Related]
23. Anti-T cell immunotoxins containing pokeweed anti-viral protein: potential purging agents for human autologous bone marrow transplantation.
Ramakrishnan S; Uckun FM; Houston LL
J Immunol; 1985 Nov; 135(5):3616-22. PubMed ID: 3900212
[TBL] [Abstract][Full Text] [Related]
24. Use of cryopreserved bone marrow in unrelated allogeneic transplantation.
Stockschläder M; Krüger W; tom Dieck A; Horstmann M; Altnöder M; Löliger C; Fiedler W; Hoffknecht M; Erttmann R; Zander A
Bone Marrow Transplant; 1996 Feb; 17(2):197-9. PubMed ID: 8640166
[TBL] [Abstract][Full Text] [Related]
25. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
[TBL] [Abstract][Full Text] [Related]
26. [Cellular sorting methods in autologous (elimination of residual malignant cells) or allogeneic (T lymphocyte elimination) bone marrow grafts. Clinical pilot studies].
Hervé P; Flesch M
Nouv Rev Fr Hematol (1978); 1986; 28(2):97-105. PubMed ID: 2942838
[TBL] [Abstract][Full Text] [Related]
27. Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Passweg J; Baldomero H; Hermans J
Bone Marrow Transplant; 1999 Aug; 24(3):231-45. PubMed ID: 10456992
[TBL] [Abstract][Full Text] [Related]
28. [Prolonged thrombocytopenia after autologous bone marrow transplantation].
Kojima S; Fukuda M; Horibe K; Matsuyama T; Takeyama K; Matsushita T; Miyamura K; Sugihara T; Minami S; Kodera Y
Rinsho Ketsueki; 1989 Feb; 30(2):175-80. PubMed ID: 2664261
[TBL] [Abstract][Full Text] [Related]
29. [In vitro manipulation of bone marrow cells for bone marrow transplantation].
Morishima Y
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3034-43. PubMed ID: 3056275
[TBL] [Abstract][Full Text] [Related]
30. Long-term cryopreservation of autologous bone marrow: analysis of granulocyte-macrophage progenitor (CFU-GM) viability in 31 samples stored more than 48 months.
Lemoli RM; Visani G; Motta MR; Rizzi S; Ricci P; Bandini G; Poluzzi C; Tura S
Haematologica; 1988; 73(2):101-4. PubMed ID: 3044937
[No Abstract] [Full Text] [Related]
31. Development of optimal techniques for cryopreservation of human platelets. I. Platelet activation during cold storage (at 22 and 8 degrees C) and cryopreservation.
Gao DY; Neff K; Xiao HY; Matsubayashi H; Cui XD; Bonderman P; Bonderman D; Harvey K; McIntyre JA; Critser J; Miraglia CC; Reid T
Cryobiology; 1999 May; 38(3):225-35. PubMed ID: 10328912
[TBL] [Abstract][Full Text] [Related]
32. Antioxidants for bone marrow cryopreservation.
Matthes G; Hübner U; Gränz M; Schütt M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):451-4. PubMed ID: 2480288
[TBL] [Abstract][Full Text] [Related]
33. Concentration of bone marrow mononuclear cells for in vitro treatment and AB0-incompatible transplantation: a rapid and reproducible procedure using the haemonetics V50 cell separator.
Wiesneth M; Hertenstein B; Koerner K; Heimpel H; Heit W
Beitr Infusionsther; 1988; 21():340-5. PubMed ID: 2463006
[TBL] [Abstract][Full Text] [Related]
34. Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group--Infectious Diseases Working Party.
Locasciulli A; Alberti A; de Bock R; Cordonnier C; Einsele H; Engelhard D; Grundy J; Reusser P; Ribaud P; Ljungman P
Bone Marrow Transplant; 1994 Nov; 14(5):833-7. PubMed ID: 7534164
[TBL] [Abstract][Full Text] [Related]
35. Parameters of cell freezing: implications for the cryopreservation of stem cells.
Hubel A
Transfus Med Rev; 1997 Jul; 11(3):224-33. PubMed ID: 9243775
[TBL] [Abstract][Full Text] [Related]
36. Autologous bone marrow transplantation for leukemia.
Stuart RK
Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
[TBL] [Abstract][Full Text] [Related]
37. A survey of allogeneic bone marrow transplant programs in the United States regarding cytomegalovirus prophylaxis and pre-emptive therapy.
Avery RK; Adal KA; Longworth DL; Bolwell BJ
Bone Marrow Transplant; 2000 Oct; 26(7):763-7. PubMed ID: 11042658
[TBL] [Abstract][Full Text] [Related]
38. Pre-stimulation of the human bone marrow CD34+ cells before storage at 4 degrees C with the early acting cytokines enhance their survival and increase proliferative potential. Transplantological implications.
Ratajczak MZ; Kuczyński WI; Skórski T; Ratajczak J
Mater Med Pol; 1993; 25(3-4):133-6. PubMed ID: 7520961
[TBL] [Abstract][Full Text] [Related]
39. [Autologous bone marrow transplantation in solid tumors in children].
Ohira M; Shibata T; Ise T
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1428-37. PubMed ID: 6347080
[TBL] [Abstract][Full Text] [Related]
40. Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates.
Ueda M; Joshi ID; Dan M; Uberti JP; Chou TH; Sensenbrenner LL; Lum LG
Transplantation; 1993 Aug; 56(2):351-6. PubMed ID: 8356589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
